Related Experiment Video
Updated: Jul 7, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Young onset dementia: enhancing the diagnostic process and post-diagnosis support
1University of Brighton and Specialist Older Adult Mental Health Services, Sussex Partnership NHS Foundation Trust, Chichester, England.
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|July 6, 2026
Summary
Young onset dementia (YOD) affects adults under 65. Early diagnosis is crucial but often delayed in younger individuals due to misrecognition and misdiagnosis, impacting care access.
Area of Science:
- Neuroscience
- Gerontology
- Neurology
Background:
- Young onset dementia (YOD) affects individuals under 65, presenting unique challenges compared to later-onset forms.
- Delayed diagnosis is common in YOD, stemming from symptom underrecognition and initial misdiagnosis.
- This delay significantly impacts patients and families, hindering timely access to essential treatments and support.
Purpose of the Study:
- To provide a comprehensive overview of young onset dementia.
- To identify barriers contributing to delayed diagnosis in younger adults.
- To discuss improvements in diagnosis and post-diagnosis support for YOD patients.
Main Methods:
- Literature review and synthesis of current knowledge on YOD.
- Analysis of diagnostic challenges and symptom presentation in younger populations.
- Exploration of potential service improvements and nursing considerations.
Main Results:
- Younger adults face longer diagnostic waiting times than older adults.
- Lack of symptom recognition and misdiagnosis are key barriers to timely YOD diagnosis.
- A case study illustrates the lived experiences of individuals with YOD and their families.
Conclusions:
- Improving early symptom recognition and diagnostic pathways is critical for YOD.
- Enhanced post-diagnosis support is essential for affected individuals and their families.
- Nurses play a vital role in advocating for and improving local YOD services.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...